Potential 100 bagger Biotech missed by the market, page-1361

DerrickJ: I do believe the highest RISK phase with any biotech investment is at the early stage - i.e. pre-clinical and also in phase 1 trials.
Hard for me to give an accurate figure but my pure "guesstimate" would be that anywhere between 35 - 50 mio (taking into account how much - or how little - money will be left over after the researches are done!) would sound about right.
I am most certainly NOT an expert in this and hopefully some other poster(s) could give you a much better and more "in-depth" reply !

wasa

As mentioned: All the best to all NSB holders/buyers

PS: And, yes, I am still holding those shares from the early days under the sublime leadership of Leslie.